CD33 and acute myeloid leukemia: For instance, Mylotarg, used in relapsed acute myeloid leukemia, features a CD33 antibody comprising an acid-sensitive cleavable linker and a DNA-damaging agent (N-acetyl-γ-calicheamicin) [35,36].